This year we will give more emphasis to live cases. We will have live cases from Milan, from Siegburg and from London.

We will demonstrate what we mean for optimal implantation of a drug eluting stent. Ultimately we believe that this strategy will further improve the safety and performance of these devices.


Live demonstrations will include treatment of adult valvular heart disease, structural heart disease and selected peripheral interventions.